Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.

نویسندگان

  • Scott D Solomon
  • Nagesh Anavekar
  • Hicham Skali
  • John J V McMurray
  • Karl Swedberg
  • Salim Yusuf
  • Christopher B Granger
  • Eric L Michelson
  • Duolao Wang
  • Stuart Pocock
  • Marc A Pfeffer
چکیده

BACKGROUND Left ventricular function is a principal determinant of cardiovascular risk in patients with heart failure. The growing number of patients with preserved systolic function heart failure underscores the importance of understanding the relationship between ejection fraction and risk. METHODS AND RESULTS We studied 7599 patients with a broad spectrum of symptomatic heart failure enrolled in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program. All patients were randomized to candesartan at a target dose of 32 mg once daily or matching placebo and followed up for a median of 38 months. We related left ventricular ejection fraction (LVEF), measured before randomization at the sites, to cardiovascular outcomes and causes of death. Mean LVEF in patients enrolled in CHARM was 38.8+/-14.9% (median LVEF 36%). Patients with lower LVEF tended to have higher baseline New York Heart Association class. The hazard ratio for all-cause mortality increased by 39% for every 10% reduction in ejection fraction below 45% (hazard ratio 1.39, 95% CI 1.32 to 1.46), with adjustment for baseline covariates. All-cause mortality, cardiovascular death, and all components of cardiovascular death declined with increasing ejection fraction until an ejection fraction of 45%, after which the risk of these outcomes remained relatively stable with increasing LVEF. The absolute change in rate per 100 patient-years for each 10% reduction in LVEF was greatest for sudden death and heart failure-related death. The effect of candesartan in reducing cardiovascular outcomes was consistent across LVEF categories. CONCLUSIONS LVEF is a powerful predictor of cardiovascular outcome in heart failure patients across a broad spectrum of ventricular function. Nevertheless, once elevated to a range above 45%, ejection fraction does not further contribute to assessment of cardiovascular risk in heart failure patients.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction

Left ventricular ejection fraction (LVEF) remains the most commonly utilized metric of cardiac function and has been related to outcomes in patients across the spectrum of heart failure (HF). In patients with HF and reduced ejection fraction (EF), LVEF had been shown to be predictive of cardiovascular death, HF hospitalization, and all-cause mortality in a relatively linear fashion, with those ...

متن کامل

Effect of Exercise Training on Heart Rate Variability in Patients with Heart Failure After Percutaneous Coronary Intervention

Background: This study aims to evaluate the effect of exercise training on heart rate variability (HRV) and to determine the correlation between parameters of HRV and the ejection fraction in patients with heart failure after percutaneous coronary intervention.Material and Methods: Fifty patients with left ventricular ejection fraction ≤ 40% undergone percutaneous coronary intervention were r...

متن کامل

Estimation of Ejection Fraction with Echocardiographic and Cardioangiographic Methods in 50 Cardiac Patients

Ejection fraction is the most important indicator of heart failure. Angiography , is a standard method to demonstrate ejection fraction but it is invasive. Therefore determination of sensitivity and specificity of echocardiography versus angiography is a good guidance for physicians. A total number of 50 patients were enrolled in a prospective study. Two dimension and M-Mode echocardiography...

متن کامل

نتایج کاربرد بالون پمپ داخل آئورت در بیماران جراحی قلبIntra-Aortic Ballon Pump Outcome in Cardiac Surgical Patients

        Background & Aim: Intra-aortic ballon pump(IABP) is a mechanical device that has become an accepted treatment modality for patients with severely compromised hemodynamics. The present retrospective study was undertaken to identify the major survival and nonsurvival determinants of patients who were in need of intra-aortic ballon pump support after cardiac surgery. Patients & Methods: Th...

متن کامل

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

BACKGROUND We wished to test previous hypotheses that sex-related differences in mortality and morbidity may be due to differences in the cause of heart failure or in left ventricular ejection fraction (LVEF) by comparing fatal and nonfatal outcomes in women and men with heart failure and a broad spectrum of left ventricular ejection fraction. METHODS AND RESULTS We compared outcomes in 2400 ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation

دوره 112 24  شماره 

صفحات  -

تاریخ انتشار 2005